Pilot Study: Selective Deglycosylation of Terminal Sialic Acid on Infliximab Increases Binding of Antibodies to Infliximab (ATI) in ATI-Positive Inflammatory Bowel Disease (IBD) Patients

Authors :: Bing Zhang
Ling Shao
Matthieu Allez
Caroline Hwang
Sarah Sheibani
My-Linh Tran-Minh
Source :: Gastroenterology. 152:S404
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Hepatology
business.industry
Gastroenterology
medicine.disease
Inflammatory bowel disease
Infliximab
Sialic acid
Antibodies to infliximab
chemistry.chemical_compound
chemistry
Immunology
medicine
business
medicine.drug

Full Text Access

Tools